We are live on ! Find out more
NP

Newlight Partners Portfolio holdings

AUM $3.9M
1-Year Est. Return 96.05%
This Fund
S&P 500
This Quarter Est. Return
-17.48%
1 Year Est. Return
-96.05%
3 Year Est. Return
-92.84%
5 Year Est. Return
-96.09%
10 Year Est. Return
AUM
$1.48B
AUM Growth
-$333M
Cap. Flow
-$14.3M
Cap. Flow %
-0.97%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HRMY icon
Harmony Biosciences
HRMY
+$10.2M
2
OWL icon
Blue Owl Capital
OWL
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 75.9%
2 Financials 13.88%
3 Technology 10.16%
4 Consumer Staples 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSH
1
DELISTED
Oak Street Health, Inc.
OSH
$1.09B 73.76%
40,509,640
OWL icon
2
Blue Owl Capital
OWL
$8.29B
$205M 13.88%
16,162,773
-327,536
-2% -$4.15M
NOVA
3
DELISTED
Sunnova Energy
NOVA
$150M 10.16%
6,505,811
HRMY icon
4
Harmony Biosciences
HRMY
$2.31B
$31.7M 2.15%
651,372
-249,452
-28% -$10.2M
LAUR icon
5
Laureate Education
LAUR
$5.36B
$787K 0.05%
66,442

Similar funds

Newlight Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Newlight Partners held 5 positions worth $1.48B, down 18% from $1.81B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 0%. Newlight Partners opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 76% a quarter earlier, followed by Financials and Technology.

  • Newlight Partners's biggest Q1 2022 reduction was Harmony Biosciences, cutting an estimated $10.2M.
  • Newlight Partners's ten largest holdings make up 100% of its $1.48B portfolio in Q1 2022.
  • Newlight Partners opened 0 new positions and closed 0 in Q1 2022.
  • Newlight Partners's portfolio value fell 18% quarter-over-quarter to $1.48B.

Based on Newlight Partners's 13F filing for Q1 2022, filed 12 May 2022.